Latest Conference Articles

Brooks Cash, MD, discusses the importance of bowel preparation and surveillance in patients with diabetes.

Anti-TNFs, vedolizumab, ustekinumab, thiopurines, and 5-ASA were all linked to a lower risk of myocardial infarctions.

A poster presented at ACG provides an updated analysis of clostridium difficile infection in the tofacitinib UC clinical program.

Sulindac and eflornithine could help delay the need for lower gastrointestinal surgery for FAP patients.

New data presented at ACG 2020 shows NER1006 bowel preparation to be safe and efficacious in patients with diabetes preparing for their colonoscopy.

Researchers test 3 different doses of mirikizumab in both biologic experienced and naïve Crohn’s disease patients.

An expert discusses a study assessing the effects of low compliance to eosinophilic esophagitis therapies among pediatric patients.

Ustekinumab resulted in a reduction of both stool frequency and rectal bleeding for ulcerative colitis patients.

New research shows patients with chronic liver disease admitted for influenza had an increased risk of disease severity but not a higher odds of mortality.

Research shows dupilumab remains effective in EoE for up to 2 years.

A new study presented at ACG shows vedolizumab to be superior to adalimumab in maintaining early disease control in patients with moderate-to-severe ulcerative colitis.

In data presented at ACG, investigators found a link between sex, lower BMI, and the development of irritable bowel syndrome in patients following a c. diff infection.

In a poster presented during ACG, investigators show data from a long-term extension of the UNIFI trial.

Patients with chronic pancreatitis can exhibit dependence on chronic opioid therapy prior to receiving total pancreatectomy with islet autotransplantation.

Isolation as a result of suspected C. Diff can take a significant financial toll on the healthcare system, thus it is necessary to determine appropriate factors that can predict CDI.

HRV-induced cytokine responses were reduced in patients with severe asthma.

Pulmonary conditions like asthma could often lead to the development of chronic cough.

Despite not being able to attend conferences live, there are some advantages to a virtual conference.

The molecular mechanisms of steroid resistance suggest the P13K/Akt signaling pathway and the MAPK signaling pathway are involved.

New cohort analysis shows an over-reliance on therapy designed as an add-on for asthma control.

Twelve-year data shows patients without control of their asthma could suffer lung failure quickly if they aren't consistent in maintenance therapy.

Asthma patients have not had higher rates of negative outcomes from COVID-19 than other individuals.

The biologic drug is set to be used as a combination therapy for asthma.

In a study presented at ERS, researchers IOS could be used for assessment level of asthma control in both adult and pediatric patients.

New data shows nearly 40% of chronic lung disease patients from a Portuguese hospital died within 5 years of initiating respiratory rehabilitation.

Patients saw improvement in symptom perception, activity limitation, emotional function, and environmental stimuli.

It has been approximately 60 years since a new treatment for coughs has come on the market.

Data shows certain personality traits are linked to a COPD patient's likelihood of active or sedentary behaviors.